Why the study?
Does a strategy of LVAD support combined with a standardized pharmacological and cardiac function monitoring protocol result in myocardial recovery and LVAD explantation in patients with Stage D heart failure?
Does a strategy of LVAD support combined with a standardized pharmacological and cardiac function monitoring protocol result in myocardial recovery and LVAD explantation in patients with Stage D heart failure?
Answers are grounded in this paper and cite their sources.
A strategy combining LVAD support with a standardized pharmacological and cardiac function monitoring protocol is feasible, reproducible across multiple centers, and results in a high rate of LVAD explantation in Stage D heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Birks et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: